utilised pleural effusion samples collected from 1,331 MM patients, whereby it was established that effusion-derived mesothelin exhibits a 95% specificity for MM; justifying the clinical utility of pleural effusion-derived mesothelin as a biomarker to facilitate a definitive diagnosis of MM (53). Here, MSLN is linked to Pleural effusion.